Effect of Recombinant Human Parathyroid Hormone (1-84) on Vertebral Fracture and Bone Mineral Density in Postmenopausal Women with Osteoporosis
Susan L. Greenspan(University of Pittsburgh), Thomas B. Marriott, Stephen Morris, David A. Hanley(The University of Sydney), Annette Mathisen, Robert S. Lindsay(National Institutes of Health), Mark P. Ettinger, Henry G. Bone(University of Arizona), Consuelo Blosch, José Zanchetta(Universidad del Salvador)
Annals of Internal Medicine
March 6, 2007
Cited by 360
Related Papers
Effect of Parathyroid Hormone (1-34) on Fractures and Bone Mineral Density in Postmenopausal Women with Osteoporosis
|New England Journal of Medicine|2001|4.6k
Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
|New England Journal of Medicine|2009|3.5k
Romosozumab in Postmenopausal Women with Low Bone Mineral Density
|New England Journal of Medicine|2014|1.2k
Adiponectin and development of type 2 diabetes in the Pima Indian population
|The Lancet|2002|1.1k